Skip to main content

Advertisement

Table 4 Immunohistochemical characteristics of ML at MNH

From: Malignant lymphomas (ML) and HIV infection in Tanzania

  IMMUNOREACTIVITY FOR:
TUMOUR LCA* CD20 CD3 CD68 MEAN Ki-67 (% +/HPF)
BL Reactive (membranous cytoplasmic) in all tumour and infiltrating cells Reactive (membranous cytoplasmic) in all tumour cells Focal (membranous cytoplasmic) reactivity in infiltrating T-cells Focal (membranous cytoplasmic) reactivity in infiltrating phagocytes 70.0
NHL Reactive (membranous cytoplasmic) in all tumour and infiltrating cells Reactive (membranous cytoplasmic) in all tumour cells Focal (membranous cytoplasmic) reactivity in infiltrating T-cells Focal (membranous cytoplasmic) reactivity in infiltrating phagocytes 40.0
HD Reactive (membranous cytoplasmic) in all tumour and infiltrating cells Focal reactivity in infiltrating B-cells while RS and Hodgkin cells negative Focal reactivity in infiltrating T-cells Focal (membranous cytoplasmic) reactivity in infiltrating phagocytes 25.0
  1. *LCA: Leucocyte common antigen (CD45)